Table 4.

ORs for prognostic features and RF risk score in the optimized set of EBC patients, using univariate and multivariate analysis

CharacteristicsOR (univariate)POR (multivariate)POR (multivariate)P
Age
 <431.01.0
 ≥430.52055.06E−030.54290.0536
Tumor size
 <2 cm1.01.0
 2–5 cm2.11150.24473.54840.1458
 >5 cm4.81240.01816.14170.0450
Grade
 I1.01.0
 II2.25330.01652.45570.0472
 III2.28580.03192.05590.1512
Lymph node status
 01.01.0
 1–34.27423.40E−063.06610.0048
 >311.87705.57E−157.67751.38E−07
HER2
 Negative1.01.0
 Positive2.32435.52E−032.45670.0170
ER
 Positive1.01.0
 Negative0.95220.91301.33700.6822
PR
 Positive1.01.0
 Negative2.60990.04374.32880.0320
Treatment arm
 A1.01.0
 B0.84490.55220.74930.4606
 C0.55630.03970.56660.1558
AoL score
 ≤52.71.01.0
 52.7–73.73.95192.04E−063.87407.13E−06
 >73.712.91381.84E−1315.3081.18E−13
RF risk score
 <0.2351.01.01.0
 >0.2352.79911.59E−053.12240.00043.47687.84E−06
  • NOTE: AoL score split into tertiles. A multivariate analysis using only RF risk score and AoL score is also reported in the last two columns.

  • Abbreviation: PR, progesterone receptor.